Development and characterization of polyclonal antibody against human kappa light chain in rabbit. 2019

Mojgan Esparvarinha, and Hamid Nickho, and Leili Aghebati-Maleki, and Jalal Abdolalizadeh, and Hadi Nasiri, and Zahra Valedkarimi, and Jafar Majidi
Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Polyclonal antibodies against kappa light chain are used to diagnose diseases producing free light chain. The kappa and lambda light chains are products of immunoglobulin synthesis and released into the circulation in minor amounts such as serum, cerebrospinal fluid, urine and synovial fluid in normal condition. The purpose of this study was the production and purification of polyclonal immunoglobulin G (IgG) against human kappa light chains. In this study, early human IgG was purified by ion-exchange chromatography, reduced with Dithiothreitol and heavy and light chains were separated with size-exclusion chromatography. Afterward, affinity chromatography with protein L Sepharose at pH 2.00 was displayed to be a dominant condition for the separation and purification of the kappa light chain of immunoglobulins from human serum. Eventually, the rabbit was immunized by human kappa light chains. The rabbit IgG was purified and labeled with horseradish peroxidase (HRP). Direct enzyme-linked immunosorbent assay was planned to determine the titer of HRP conjugated rabbit IgG against the human kappa light chain. The optimum titer of anti-kappa IgG was 1:16000. At the result, purified polyclonal anti-kappa is useful tool in biomedical and biochemical researches and diagnostic kits.

UI MeSH Term Description Entries

Related Publications

Mojgan Esparvarinha, and Hamid Nickho, and Leili Aghebati-Maleki, and Jalal Abdolalizadeh, and Hadi Nasiri, and Zahra Valedkarimi, and Jafar Majidi
August 1991, Hybridoma,
Mojgan Esparvarinha, and Hamid Nickho, and Leili Aghebati-Maleki, and Jalal Abdolalizadeh, and Hadi Nasiri, and Zahra Valedkarimi, and Jafar Majidi
January 2022, Open life sciences,
Mojgan Esparvarinha, and Hamid Nickho, and Leili Aghebati-Maleki, and Jalal Abdolalizadeh, and Hadi Nasiri, and Zahra Valedkarimi, and Jafar Majidi
February 2011, Journal of biotechnology,
Mojgan Esparvarinha, and Hamid Nickho, and Leili Aghebati-Maleki, and Jalal Abdolalizadeh, and Hadi Nasiri, and Zahra Valedkarimi, and Jafar Majidi
March 2008, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology,
Mojgan Esparvarinha, and Hamid Nickho, and Leili Aghebati-Maleki, and Jalal Abdolalizadeh, and Hadi Nasiri, and Zahra Valedkarimi, and Jafar Majidi
February 1990, Arthritis and rheumatism,
Mojgan Esparvarinha, and Hamid Nickho, and Leili Aghebati-Maleki, and Jalal Abdolalizadeh, and Hadi Nasiri, and Zahra Valedkarimi, and Jafar Majidi
January 2017, Protein and peptide letters,
Mojgan Esparvarinha, and Hamid Nickho, and Leili Aghebati-Maleki, and Jalal Abdolalizadeh, and Hadi Nasiri, and Zahra Valedkarimi, and Jafar Majidi
July 2011, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology,
Mojgan Esparvarinha, and Hamid Nickho, and Leili Aghebati-Maleki, and Jalal Abdolalizadeh, and Hadi Nasiri, and Zahra Valedkarimi, and Jafar Majidi
December 2004, Journal of immunology (Baltimore, Md. : 1950),
Mojgan Esparvarinha, and Hamid Nickho, and Leili Aghebati-Maleki, and Jalal Abdolalizadeh, and Hadi Nasiri, and Zahra Valedkarimi, and Jafar Majidi
October 2015, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology,
Mojgan Esparvarinha, and Hamid Nickho, and Leili Aghebati-Maleki, and Jalal Abdolalizadeh, and Hadi Nasiri, and Zahra Valedkarimi, and Jafar Majidi
January 1984, Annales d'immunologie,
Copied contents to your clipboard!